UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $3.4M invested in Proshares UltraPro NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
Calls
$552K
Puts
$235K
Net Calls
+$317K
Net Calls Change
+$301K
Name Holding Trade Value Shares
Change
Shares
Change %
TRCT
1
Tower Research Capital (TRC)
New York
$1.28M +$1.28M +38,065 New
ACM
2
Avalon Capital Management
California
$818K +$818K +24,329 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$649K -$371K -11,031 -36%
Jane Street
4
Jane Street
New York
$527K +$188K +5,597 +56%
UBS Group
5
UBS Group
Switzerland
$101K +$101K +3,003 New
CG
6
Cutler Group
California
$13K +$9.75K +300 +300%
Morgan Stanley
7
Morgan Stanley
New York
$10K -$20K -600 -67%